1-(naphthalen-2-ylsulfonyl)-1H-indole | 247168-02-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 1-(naphthalen-2-ylsulfonyl)-1H-indole
• 英文别名: 1-(naphthalene-2-sulfonyl)-1H-indole；1-(2-naphthalenesulfonyl)-indole；1-(2-naphthylsulfonyl)-1H-indole；1-(2-naphthylsulfonyl)indole；1-naphthalen-2-ylsulfonylindole
• CAS: 247168-02-1
• 化学式: C₁₈H₁₃NO₂S
• 分子量: 307.373
• InChiKey: OQXCDXOFSOQVFD-UHFFFAOYSA-N

物化性质

• 熔点：
  101-102.5 °C
• 沸点：
  539.1±33.0 °C(Predicted)
• 密度：
  1.28±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  22
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  47.4
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-(naphthalen-2-ylsulfonyl)-1H-indole 在 正丁基锂 、 溶剂黄146 作用下， 以 四氢呋喃 、 正己烷 、 丙酮 为溶剂， 反应 4.5h， 生成 4-hydroxy-4-[1-(naphthalene-2-sulfonyl)-1H-indol-2-yl]-cyclohexa-2,5-dienone
  参考文献：
  名称：

  Quinols as Novel Therapeutic Agents. 2. 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and Related Agents as Potent and Selective Antitumor Agents

  摘要：

  A series of substituted 4-(1-arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2, 5-dien-1-ones (indolylquinols) has been synthesized on the basis of the discovery of lead compound la and screened for antitumor activity. Synthesis of this novel series was accomplished via the one-pot" addition of lithiated (arylsulfonyl)indoles to 4,4-dimethoxycyclohexa-2,5-dienone followed by deprotection under acidic conditions. Similar methodology gave rise to the related naphtho-, 1H-indole-, and benzimidazole-substituted quinols. A number of compounds in this new series were found to possess in vitro human tumor cell line activity substantially more potent than the recently reported antitumor 4-substituted 4-hydroxycyclohexa-2,5-dien-1-ones(1) with similar patterns of selectivity against colon, renal, and breast cell lines. The most potent compound in the series in vitro, 4-(1-benzenesulfonyl-6-fluoro-1H-indol-2-yl)-4-hydroxycyclohexa-2,5-dienone (1h), exhibits a mean GI(50) value of 16 nM and a mean LC50 value of 2.24 muM in the NCl 60cell-line screen, with LC50 activity in the HCT 116 human colon cancer cell line below 10 nM. The crystal structure of the unsubstituted indolylquinol la exhibits two independent, molecules. both participating in intermolecular hydrogen bonds from quinol OH to carbonyl O-2 but one OH group also interacts intramolecularly with a sulfonyl O atom. This interaction, which strengthens upon ab initio optimization, may influence the chemical environment. of the bioactive quinol moiety. In vivo, significant antitumor activity was recorded (day 28) in mice bearing subcutaneously implanted MDA-MB-435 xenografts, following intraperitoneal treatment of mice with compound 1a at 50 mg/kg.

  DOI：

  10.1021/jm040859h
• 作为产物：
  描述：

  吲哚 、 2-萘磺酰氯 在 sodium hydride 作用下， 以 四氢呋喃 为溶剂， 反应 1.25h， 以56%的产率得到1-(naphthalen-2-ylsulfonyl)-1H-indole
  参考文献：
  名称：

  5-HT 6受体的基于2-氨基咪唑的拮抗剂–胺能GPCR配体设计的新概念

  摘要：

  提出了一种设计胺能GPCR配体的新策略–使用芳族，杂环碱性部分代替常绿哌嗪或脂环族和脂肪族胺。该假设已通过使用一系列基准的5-HT 6 R拮抗剂进行了测试，这些拮抗剂是通过将各种取代的2-氨基咪唑基团偶联至完善的1-苯磺酰基-1 H-吲哚（用作配体核心）而获得的。晶体学研究表明，质子化后，2-氨基咪唑片段触发共振驱动的构象变化，从而导致更高的亲和力。这种分子转换可能是造成5-HT 6差异的原因具有不同胺样片段的化学型的R活性。考虑到嵌入的胍片段的多个功能化位点，构建了各种文库，并建立了结构与活性，代谢稳定性和溶解度之间的关系。N-（1 H-咪唑-2-基）酰基酰胺化学型（10a – z）的化合物对5-HT 6 R表现出高亲和力，对5-HT 1A，5-HT 2A，5-HT 7的选择性很高和D 2受体（结合可忽略不计），这归因于其非常弱的碱性。已显示4-甲基-5- [1-（萘-1-磺酰基）-1 H-吲哚-3-基]

  DOI：

  10.1016/j.ejmech.2019.06.001

文献信息

• Triflic acid controlled successive annelation of aromatic sulfonamides: an efficient one-pot synthesis of N-sulfonyl pyrroles, indoles and carbazoles
  作者：Mohammed Abid、Liliana Teixeira、Béla Török

  DOI：10.1016/j.tetlet.2007.04.021

  日期：2007.6

  A novel one-pot synthesis of N-substituted heterocycles via successive cyclization/annelation starting from primary sulfonamides is described. This process leads directly to N-sulfonyl pyrroles, indoles and carbazoles. The selection of appropriate reactant/triflic acid ratio successfully controls the formation of the desired product.

  描述了一种从伯磺酰胺开始通过连续环化/退火来合成 N-取代杂环的新型一锅法。该过程直接生成N-磺酰基吡咯、吲哚和咔唑。选择适当的反应物/三氟甲磺酸比率成功地控制了所需产物的形成。
• 4-(1-(sulfonyl)-1h-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds and analogs thereof as therapeutic agents
  申请人：Stevens Francis Graham Malcolm

  公开号：US20060100265A1

  公开（公告）日：2006-05-11

  This invention pertains to certain 4-(1-(sulfonyl)-1H-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds, and analogs thereof, including compounds of the following formula, which are, inter alia, antiproliferative agents, anticancer agents, and/or thioredoxin/thioredoxin reductase inhibitors: formula (I) wherein: Ar is a 1-(sulfonyl)-1H-indol-2-yl group; the bond marked α is independently: (a) a single bond; or: (b) a double bond; the bond marked β is independently: (a) a single bond; or: (b) a double bond; the group —OR O is independently: (a) —OH; (b) an ether group (e.g., —OMe); or: (c) an acyloxy (i.e., reverse ester) group (e.g., —OC(═O)Me); each of R 2 , R 3 , R 5 , and R 6 , is independently a ring substituent and is: (a) H; (b) a monovalent monodentate substituent; or: (c) a ring substituent which, together with an adjacent ring substituent, and together with the ring atoms to which these ring substituents are attached, form a fused ring; and pharmaceutically acceptable salts, esters, amides, solvates, hydrates, and protected forms thereof. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, for example, in the treatment of proliferative conditions, (e.g., cancer), and/or conditions mediated by thioredoxin/thioredoxin reductase.

  本发明涉及某些4-(1-(磺酰基)-1H-吲哚-2-基)-4-(羟基)-环己-2,5-二酮化合物及其类似物，包括以下式的化合物，它们是抗增殖剂、抗癌剂和/或硫代还蛋白/硫代还蛋白还原酶抑制剂等：式(I)其中：Ar是1-(磺酰基)-1H-吲哚-2-基；标记为α的键独立地是：(a) 单键；或：(b) 双键；标记为β的键独立地是：(a) 单键；或：(b) 双键；—ORO基团独立地是：(a) -OH；(b) 醚基团（例如，-OMe）；或：(c) 酰氧基（即反酯基）基团（例如，-OC（═O）Me）；R2、R3、R5和R6中的每一个独立地是一个环取代基，并且是：(a) H；(b) 单价单齿取代基；或：(c) 与相邻的环取代基一起，并且与这些环取代基附着的环原子一起形成融合环的环取代基；以及其药学上可接受的盐、酯、酰胺、溶剂化物、水合物和保护形式。本发明还涉及包含这样的化合物的制药组合物，以及这样的化合物和组合物的使用，无论是体外还是体内，例如在治疗增殖性疾病（例如癌症）和/或由硫代还蛋白/硫代还蛋白还原酶介导的疾病中。
• ZnO-mediated regioselective C-arylsulfonylation of indoles: a facile solvent-free synthesis of 2- and 3-sulfonylindoles and preliminary evaluation of their activity against drug-resistant mutant HIV-1 reverse transcriptases (RTs)
  作者：Graziella Tocco、Michela Begala、Francesca Esposito、Pierluigi Caboni、Valeria Cannas、Enzo Tramontano

  DOI：10.1016/j.tetlet.2013.09.017

  日期：2013.11

  A ZnO-mediated one-pot solvent-free protocol for the regioselective C-arylsulfonylation of indoles is described and some novel derivatives were tested on wild type and non-nucleoside inhibitor resistant K103N and Y181C HIV-1 reverse transcriptases (RTs). (C) 2013 Elsevier Ltd. All rights reserved.
• 2-Naphthalenesulfonyl as a Tosyl Substitute for Protection of Amino Functions. Cyclic Voltammetry Studies on Model Sulfonamides and Their Preparative Cleavage by Reduction
  作者：Barthélémy Nyasse、Leif Grehn、Hernani L. S. Maia、Luis S. Monteiro、Ulf Ragnarsson

  DOI：10.1021/jo990695q

  日期：1999.9.1

  With the aim to develop a practically useful, reductively more labile alternative to tosyl for protection of amino functions, initially a number of N-arenesulfonyl-protected heterocycles (pyrroles, imidazoles, indole, and carbazole) have been prepared and studied by cyclic voltammetry (CV). The recorded activation potentials vary from -1.32 to -1.99 V (vs SCE). In N-sulfonylazolides such as tosylindole the cathodic potentials are shifted by over 0.5 V compared to simple sulfonamides. An additional effect of the sulfonic acid component is also indicated. Among the compounds studied, 1- and 2-naphthalenesulfollylindole give CV peaks at about 0.4 and 0.2 V, respectively, less negative potential than tosylindole. To further investigate naphthalenesulfonyl for this purpose, we have also prepared a variety of simple 1- and 2-naphthalenesulfonyl derivatives and studied them similarly. They have activation potentials above -2.14 V and are all smoothly cleaved by Mg/MeOH. The latter reagent is capable of cleaving N-arenesulfonyl derivatives that give CV peaks above -2.30 V, whereas Al(Hg) requires potentials above about -1.7 V. Selective cleavage of 2-naphthalenesulfonyl in the presence of tosyl by Mg/MeOH is demonstrated. Several examples of reductive cleavage of arenesulfonyl derivatives with Mg/MeOH, Al(Hg), and electrolysis on a preparative scale are given.
• HETEROCYCLINDAZOLE AND AZAINDAZOLE COMPOUNDS AS 5-HYDROXYTRYPTAMINE-6 LIGANDS
  申请人：Wyeth

  公开号：EP1355904A2

  公开（公告）日：2003-10-29